Moderate
Suspected
विवरण
Carbamazepine may reduce levodopa efficacy through enzyme induction and pharmacodynamic antagonism, potentially worsening Parkinson's disease control.
तंत्र
Carbamazepine induces hepatic enzymes that metabolize levodopa's carbidopa component, potentially increasing peripheral levodopa breakdown; it may also block dopaminergic effects centrally.
नैदानिक महत्व
Worsening motor function has been reported in Parkinson's patients starting carbamazepine; tremor and rigidity may increase.
प्रबंधन
Monitor motor function closely; levodopa dose increase may be needed; consider alternative anticonvulsants (lamotrigine, gabapentin).